Abstract：
Guidelines are more accessible than ever and represent an important tool in clinical practice. The National Institute for Health and Care Excellence (NICE) has developed recommendations for heart failure diagnosis and management based not only on morbidity and mortality trial outcome data but also in-depth economic analysis, with a focus on generalisability to UK National Health Service clinical practice. There is broad consistency in structure and content between NICE guidelines and those produced by major cardiovascular organisations such as the American College of Cardiology/American Heart Association and the European Society of Cardiology. However, important differences do exist-largely attributable to publication timing-a factor that is enhanced by the rapid pace of heart failure research. This article reviews the most recent iteration of NICE chronic heart failure guidelines and compares them with major guidelines on an international scale. Variations in recommendations will be explored including implications for NICE guideline updates in the future.
摘要：
指南比以往任何时候都更容易获得，并且是临床实践中的重要工具。美国国家健康与护理卓越研究所（NICE）不仅基于发病率和死亡率试验结果数据，而且基于深入的经济分析，制定了心力衰竭诊断和管理建议。重点是英国国家卫生服务临床实践的普遍性。NICE指南与美国心脏病学会/美国心脏协会和欧洲心脏病学会等主要心血管组织制定的指南在结构和内容上具有广泛的一致性。然而,确实存在重要的差异-主要归因于发表时间-心力衰竭研究的快速发展增强了这一因素.本文回顾了NICE慢性心力衰竭指南的最新版本，并将其与国际范围内的主要指南进行了比较。将探讨建议的变化，包括对未来NICE指南更新的影响。
